Skip to main content
Clinical Trials/NCT02847689
NCT02847689
Completed
Not Applicable

Listening to Mom in the Neonatal Intensive Care Unit (NICU): Neural, Clinical and Language Outcomes

Stanford University1 site in 1 country46 target enrollmentJuly 2016
ConditionsPremature Birth

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Premature Birth
Sponsor
Stanford University
Enrollment
46
Locations
1
Primary Endpoint
White matter mean diffusivity
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The purpose of this study is to examine whether playing recordings of a mother's voice to her infant while in the hospital nursery is an effective treatment for promoting healthy brain and language development in infants born preterm.

Detailed Description

Children born preterm are at-risk for developmental language delays. Language problems in preterm children are thought to be related to neurobiological factors, including injuries to white matter structures of the brain and environmental factors, including decreased exposure to maternal speech in the hospital nursery. There is evidence to suggest that maternal speech input may be important for promoting healthy brain and language development. Participants will be randomly assigned to one of two study groups. Each infant has a 50% chance of being assigned to the group that will listen to a recording of his/her mother's voice and a 50% chance of being assigned to the group that will not be played a voice recording. Mother's of participating infants will have her voice recorded as she reads a common children's storybook. Recordings will be played to infants each day until s/he is discharged from the hospital. Participation in this study requires that all infants receive up to an additional 10 minutes of brain scans as part of his/her routine clinical magnetic resonance imaging (MRI).

Registry
clinicaltrials.gov
Start Date
July 2016
End Date
October 1, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Katherine E Travis, PhD

Instructor

Stanford University

Eligibility Criteria

Inclusion Criteria

  • Infants born preterm at Stanford Children's Hospital between 27 0/7 - 31 6/7 weeks gestational age

Exclusion Criteria

  • Congenital anomalies
  • Recognizable malformation syndromes
  • Active seizure disorders
  • History of Central Nervous System infections
  • Hydrocephalus
  • Major sensori-neural hearing loss
  • Likelihood to be transferred from NICU to alternate care facility or home environment prior to 36 weeks PMA
  • Intraventricular Hemorrhage Grades III-IV
  • Cystic periventricular leukomalacia (PVL)
  • Surgical treatment for necrotizing enterocolitis

Outcomes

Primary Outcomes

White matter mean diffusivity

Time Frame: 36-37 weeks post-menstrual age or at time of hospital discharge, whichever comes first

Mean diffusivity measures the average rate of water diffusion within a given MRI voxel.

Secondary Outcomes

  • Length of hospital stay(Days in hospital since birth and until discharge, average range is 37-40 weeks postmenstrual age (PMA))
  • Average daily weight gain(measured daily and beginning at start of treatment and until end of treatment, approximately 37-40 weeks PMA)
  • Time (days) to full oral feed(measured daily and beginning at start of treatment and until end of treatment, approximately 37-40 weeks PMA)
  • Number of significant apnea and bradycardia events requiring stimulation(measured daily and beginning at start of treatment and until end of treatment, approximately 37-40 weeks PMA)

Study Sites (1)

Loading locations...

Similar Trials